Stories of "Chicken Little" and how we "model" our world. Should we always be the center of those models? In our moment of existential dread, new data seems to suggest we got the dinosaur extinction wrong. Finally, in six months, we will have our first national election in the time of COVID-19; how should we prepare?

"Although the epidemiology of COVID-19 is evolving, we have determined that there is a large overlap between causes of deaths of COVID-19 patients and the diseases that are affected by long-term exposure to fine particulate matter (PM2.5).”
It is a great leap from overlap to claiming PM2.5 results in "excess" mortality from COVID-19. But what the heck, why let the fear generated by COVID-19 go to waste?

Even though we've been isolated from each other and the world at large, that doesn't mean we here at ACSH haven't been making our voices heard across the media landscape. In fact, with the COVID-19 pandemic raging on, our views on medical and scientific matters have been in even greater demand. And it's our view that there's no better way to spend our working hours at home than to provide clarity and calming guidance during this coronavirus health crisis.

Among the many lessons of the COVID-19 pandemic is how cumbersome one‐​size‐​fits‐​all regulations, administered by an impersonal bureaucracy, hamper a rapid and flexible response to an evolving public health emergency. The U.S. Navy Medical Corps provides us with a recent example.

Twitter captures geolocation data in about 3% of tweets. Two researchers from Johns Hopkins released a report on the changes in our social mobility. How much we are traveling, based on that dataset?

Scammers like to scare the elderly using coronavirus and Social Security fraud. Now, the AARP likes to scare old people over the food they eat.

Everyone take a deep breath and relax. During these crazy times, people are making all kinds of wild predictions about what drug or vaccine will work. Dr. David Shlaes takes a sobering look at the chances for any of these therapies to work. It's not as easy as you'd think. We should all lower our expectations a bit.

For a simple drug, there sure is a lot of controversy surrounding hydroxychloroquine -- a malaria drug that's one of a handful of repurposed drugs being evaluated as potential anti-coronavirus treatments. However, hydroxychloroquine (HCQ) doesn't look especially promising. Dr. Katherine Seley-Radtke, Professor of Chemistry and Biochemistry at the University of Maryland-Baltimore County, explains.

Vaccines, antivirals, and antibodies are all possible strategies to treat the novel coronavirus. When will these potential COVID-19 therapies be available? And will they work?

An occasional feature where a picture is indeed worth a thousand words.